FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3121027241> ?p ?o ?g. }

• W3121027241 abstract "Abstract Background Severe early onset (less than 34 weeks gestation) intrahepatic cholestasis of pregnancy (ICP) affects 0.1% of pregnant women in Australia and is associated with a 3-fold increased risk of stillbirth, fetal hypoxia and compromise, spontaneous preterm birth, as well as increased frequencies of pre-eclampsia and gestational diabetes. ICP is often familial and overlaps with other cholestatic disorders. Treatment options for ICP are not well established, although there are limited data to support the use of ursodeoxycholic acid (UDCA) to relieve pruritus, the main symptom. Rifampicin, a widely used antibiotic including in pregnant women, is effective in reducing pruritus in non-pregnancy cholestasis and has been used as a supplement to UDCA in severe ICP. Many women with ICP are electively delivered preterm, although there are no randomised data to support this approach. Methods We have initiated an international multicentre randomised clinical trial to compare the clinical efficacy of rifampicin tablets (300 mg bd) with that of UDCA tablets (up to 2000 mg daily) in reducing pruritus in women with ICP, using visual pruritus scores as a measuring tool. Discussion Our study will be the first to examine the outcomes of treatment specifically in the severe early onset form of ICP, comparing “standard” UDCA therapy with rifampicin, and so be able to provide for the first-time high-quality evidence for use of rifampicin in severe ICP. It will also allow an assessment of feasibility of a future trial to test whether elective early delivery in severe ICP is beneficial. Trial identifiers Australian New Zealand Clinical Trials Registration Number (ANZCTR): 12618000332224p (29/08/2018). HREC No: HREC/18/WCHN/36. EudraCT number: 2018–004011-44. IRAS: 272398. NHMRC registration: APP1152418 and APP117853." @default.
• W3121027241 created "2021-01-18" @default.
• W3121027241 creator A5001643442 @default.
• W3121027241 creator A5002654216 @default.
• W3121027241 creator A5004395512 @default.
• W3121027241 creator A5005347157 @default.
• W3121027241 creator A5012438434 @default.
• W3121027241 creator A5012654862 @default.
• W3121027241 creator A5014807775 @default.
• W3121027241 creator A5015816407 @default.
• W3121027241 creator A5019535085 @default.
• W3121027241 creator A5021661696 @default.
• W3121027241 creator A5022290407 @default.
• W3121027241 creator A5024647158 @default.
• W3121027241 creator A5027703526 @default.
• W3121027241 creator A5029718313 @default.
• W3121027241 creator A5042438998 @default.
• W3121027241 creator A5044391206 @default.
• W3121027241 creator A5047072180 @default.
• W3121027241 creator A5050844526 @default.
• W3121027241 creator A5052297121 @default.
• W3121027241 creator A5053156352 @default.
• W3121027241 creator A5057108059 @default.
• W3121027241 creator A5058355007 @default.
• W3121027241 creator A5060720069 @default.
• W3121027241 creator A5066834399 @default.
• W3121027241 creator A5069953239 @default.
• W3121027241 creator A5071021265 @default.
• W3121027241 creator A5073641138 @default.
• W3121027241 creator A5076356817 @default.
• W3121027241 creator A5077434986 @default.
• W3121027241 creator A5077980646 @default.
• W3121027241 creator A5084592139 @default.
• W3121027241 creator A5086082111 @default.
• W3121027241 creator A5088267333 @default.
• W3121027241 creator A5090795384 @default.
• W3121027241 date "2021-01-12" @default.
• W3121027241 modified "2023-10-12" @default.
• W3121027241 title "A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial" @default.
• W3121027241 cites W133548050 @default.
• W3121027241 cites W1743326055 @default.
• W3121027241 cites W1965779979 @default.
• W3121027241 cites W1979436743 @default.
• W3121027241 cites W1991557554 @default.
• W3121027241 cites W2016202086 @default.
• W3121027241 cites W2020621822 @default.
• W3121027241 cites W2034819949 @default.
• W3121027241 cites W2041764290 @default.
• W3121027241 cites W2068115199 @default.
• W3121027241 cites W2075182699 @default.
• W3121027241 cites W2109866339 @default.
• W3121027241 cites W2112669742 @default.
• W3121027241 cites W2117398007 @default.
• W3121027241 cites W2121957461 @default.
• W3121027241 cites W2126220199 @default.
• W3121027241 cites W2134985318 @default.
• W3121027241 cites W2138520317 @default.
• W3121027241 cites W2155764171 @default.
• W3121027241 cites W2161412395 @default.
• W3121027241 cites W2467945232 @default.
• W3121027241 cites W2530089141 @default.
• W3121027241 cites W2533149033 @default.
• W3121027241 cites W2754719178 @default.
• W3121027241 cites W2754760474 @default.
• W3121027241 cites W2912839392 @default.
• W3121027241 cites W2966395542 @default.
• W3121027241 cites W3022285062 @default.
• W3121027241 cites W3045660148 @default.
• W3121027241 doi "https://doi.org/10.1186/s12884-020-03481-y" @default.
• W3121027241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7802989" @default.
• W3121027241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33435904" @default.
• W3121027241 hasPublicationYear "2021" @default.
• W3121027241 type Work @default.
• W3121027241 sameAs 3121027241 @default.
• W3121027241 citedByCount "20" @default.
• W3121027241 countsByYear W31210272412021 @default.
• W3121027241 countsByYear W31210272412022 @default.
• W3121027241 countsByYear W31210272412023 @default.
• W3121027241 crossrefType "journal-article" @default.
• W3121027241 hasAuthorship W3121027241A5001643442 @default.
• W3121027241 hasAuthorship W3121027241A5002654216 @default.
• W3121027241 hasAuthorship W3121027241A5004395512 @default.
• W3121027241 hasAuthorship W3121027241A5005347157 @default.
• W3121027241 hasAuthorship W3121027241A5012438434 @default.
• W3121027241 hasAuthorship W3121027241A5012654862 @default.
• W3121027241 hasAuthorship W3121027241A5014807775 @default.
• W3121027241 hasAuthorship W3121027241A5015816407 @default.
• W3121027241 hasAuthorship W3121027241A5019535085 @default.
• W3121027241 hasAuthorship W3121027241A5021661696 @default.
• W3121027241 hasAuthorship W3121027241A5022290407 @default.
• W3121027241 hasAuthorship W3121027241A5024647158 @default.
• W3121027241 hasAuthorship W3121027241A5027703526 @default.
• W3121027241 hasAuthorship W3121027241A5029718313 @default.
• W3121027241 hasAuthorship W3121027241A5042438998 @default.
• W3121027241 hasAuthorship W3121027241A5044391206 @default.
• W3121027241 hasAuthorship W3121027241A5047072180 @default.
• W3121027241 hasAuthorship W3121027241A5050844526 @default.
• W3121027241 hasAuthorship W3121027241A5052297121 @default.
• W3121027241 hasAuthorship W3121027241A5053156352 @default.
• W3121027241 hasAuthorship W3121027241A5057108059 @default.

• next